The variety of potentially useful dyes or haptenes available for fluorescent nucleic acid hybridization assays is far greater than what can be obtained from commercial sources 1,2. Since this ...

The increasing incidence of genetic and rare diseases is a major factor driving revenue growth in the Antisense ...

Advancements in manufacturing technologies is a key driver driving nucleic acid therapeutics CDMO market revenue growth.

COVID-19 has significantly emphasized the importance of reliable nucleic acid-based tools that can effectively detect and control the spread of infectious diseases. Herein, we report a plasmonic fiber ...